โ† back to jobs
> job detail
O
๐Ÿ‘ฝOther

Bioanalytical Scientist

Orumtherapeutics ยท Daejeon, Korea, Korea (South)
// classified as
Other (Adjacent or hard to classify.)
posted
1d ago
location
Daejeon, Korea, Korea (South)
languages
โ€”
tools
โ€”
> description

Bioanalytical Scientist

Chemistry

Start Date: 6/15/2026

Location: Daejeon office, KRโ€ฏ (Hybrid: Yes)

ย 

General Summaryย 

์˜ค๋ฆ„ํ…Œ๋ผํ“จํ‹ฑ์€ Bioanalytical(BioA) ๋ฐ PK/PD ๊ธฐ๋Šฅ์„ ๋ฆฌ๋”ฉํ•  ์—ญ๋Ÿ‰ ์žˆ๋Š” Scientist๋ฅผ ์ฐพ๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค.
๋ณธ ํฌ์ง€์…˜์€ ํ•ญ์ฒด์™€ ์†Œ๋ถ„์ž ๋ถ„์„์˜ ๊ต์ฐจ ์˜์—ญ์—์„œ, ํŠนํžˆ ADC(Antibody-Drug Conjugate)์˜ ๋ณต์žกํ•œ ํŠน์„ฑ์„ ์ •๋ฐ€ํ•˜๊ฒŒ ๋ถ„์„ํ•˜๊ณ  ํ•ด์„ํ•˜๋Š” ์—ญํ• ์„ ์ˆ˜ํ–‰ํ•ฉ๋‹ˆ๋‹ค.
ํ•ด๋‹น ํฌ์ง€์…˜์€ ๋‚ด๋ถ€ ๋ถ„์„๋ฒ• ๊ฐœ๋ฐœ๋ถ€ํ„ฐ ๊ธ€๋กœ๋ฒŒ CRO ๊ด€๋ฆฌ๊นŒ์ง€ bioanalytical ์ „๋ฐ˜์„ ์ด๊ด„ํ•˜๋ฉฐ, GLP/GCP ํ™˜๊ฒฝ์—์„œ ์‹ ๋ขฐ๋„ ๋†’์€ ๋ฐ์ดํ„ฐ๋ฅผ ์ƒ์„ฑํ•˜๋Š” ๋ฐ ํ•ต์‹ฌ์ ์ธ ์—ญํ• ์„ ํ•ฉ๋‹ˆ๋‹ค. ๋˜ํ•œ ๋‹จ์ˆœ ๋ถ„์„์„ ๋„˜์–ด, PK ๋ฐ์ดํ„ฐ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ ์ธ์‚ฌ์ดํŠธ๋ฅผ ๋„์ถœํ•˜๊ณ  ํ›„๋ณด๋ฌผ์งˆ ์„ ์ • ๋ฐ ๊ฐœ๋ฐœ ์ „๋žต์— ๊ธฐ์—ฌํ•˜๋Š” ์ „๋žต์  ํŒŒํŠธ๋„ˆ๋กœ์„œ ํ”„๋กœ์ ํŠธ ํŒ€๊ณผ ๊ธด๋ฐ€ํžˆ ํ˜‘์—…ํ•˜๊ฒŒ ๋ฉ๋‹ˆ๋‹ค.


์ฃผ์š”์—…๋ฌด

  • ์•ฝ๋ฌผ ์ตœ์ ํ™”๋ถ€ํ„ฐ IND ์ œ์ถœ๊นŒ์ง€ ADC ๋˜๋Š” ๋ฐ”์ด์˜ค์˜์•ฝํ’ˆ ํ”„๋กœ๊ทธ๋žจ์„ ์œ„ํ•œ bioanalytical PK/PD ์ „๋žต ์ˆ˜๋ฆฝ ๋ฐ ์ˆ˜ํ–‰
  • Total antibody ๋ฐ conjugated & free payload ๋“ฑ ๋‹ค์ค‘ ๋ถ„์„ ๋Œ€์ƒ ๊ธฐ๋ฐ˜์˜ bioanalytical ๋ถ„์„ ์„ค๊ณ„ ๋ฐ ์šด์˜
  • In vitro ๋ฐ in vivo ADME ์—ฐ๊ตฌ(๋Œ€์‚ฌ, ์•ฝ๋ฌผ์ƒํ˜ธ์ž‘์šฉ ๋“ฑ) ์ˆ˜ํ–‰ ๋˜๋Š” ๊ด€๋ฆฌ
  • LC-MS/MS ๋ฐ Ligand-Binding Assay(LBA) ๊ธฐ๋ฐ˜์˜ ๋ถ„์„ ์ˆ˜ํ–‰ ๋˜๋Š” ๊ด€๋ฆฌ
  • ์™ธ๋ถ€ CRO์™€ ํ˜‘์—…ํ•˜์—ฌ method transfer, development, validation, trouble shooting ์ง„ํ–‰ ๋ฐ ๊ด€๋ฆฌ
  • GLP/GCP ๊ธฐ์ค€๊ณผ FDA ์ง€์นจ์— ๋”ฐ๋ฅธ SOP, validation report, bioanalytical ์—ฐ๊ตฌ ๊ณ„ํš ๊ฒ€ํ†  ๋ฐ ์Šน์ธ
  • ๋‹คํ•™์ œ๊ฐ„ ํ”„๋กœ์ ํŠธ์˜ Bioanalysis/PK ๋ถ„์•ผ Subject Matter Expert(SME) ์—ญํ•  ์ˆ˜ํ–‰
  • R&D ๋ฐ Clinical ๋“ฑ ์œ ๊ด€ ๋ถ€์„œ์™€ ํ˜‘์—…์„ ํ†ตํ•ด ํ”„๋กœ์ ํŠธ ๋งˆ์ผ์Šคํ†ค ๋‹ฌ์„ฑ ์ง€์›
  • IND/IB ๋“ฑ ๊ทœ์ œ ์ œ์ถœ ๋ฌธ์„œ ์ž‘์„ฑ ์‹œ BioA, PK ์„น์…˜ ์ฑ…์ž„ ์ง‘ํ•„ ๋ฐ GLP/GCP์™€ FDA/EMA์˜ bioanalytical ์ง€์นจ ์™„์ „ ์ค€์ˆ˜ ๋ณด์žฅ

์ž๊ฒฉ์‚ฌํ•ญ

  • Analytical Chemistry ๋˜๋Š” ๊ด€๋ จ ๋ถ„์•ผ ๋ฐ•์‚ฌ ์ด์ƒ ํ•™์œ„ ๋ฐ ํ•™์œ„ ์ทจ๋“ ํ›„ 5๋…„ ์ด์ƒ์˜ ๊ด€๋ จ ๊ฒฝ๋ ฅ
  • LC-MS/MS ๋ฐ LBA ๋“ฑ์˜ ๋ถ„์„๋ฒ• ํ™œ์šฉ์„ ํ™œ์šฉํ•œ ADC ์•ฝ๋ฌผ์˜ PK ๋ฐ ์ƒ์ฒด ๋‚ด ๋ถ„ํฌ (biodistribution) ์—ฐ๊ตฌ ๊ฒฝํ—˜
  • Total antibody, Free/Conjugated payload ๋ฐ ํ•ญ-์•ฝ๋ฌผ ํ•ญ์ฒด (ADA) ๋ถ„์„์„ ํฌํ•จํ•œ ADC ๋ชจ๋‹ฌ๋ฆฌํ‹ฐ์šฉ ๋ฐ”์ด์˜ค ๋ถ„์„๋ฒ• ๊ฐœ๋ฐœ, ๊ฒ€์ฆ ๋ฐ ์‹คํ–‰
  • ์ดˆ๊ธฐ ํƒ€๋‹น์„ฑ ๊ฒ€ํ† ๋ถ€ํ„ฐ ํ›„๋ณด๋ฌผ์งˆ ์„ ์ •(Candidate nomination) ๋‹จ๊ณ„์˜ ์Šคํฌ๋ฆฌ๋‹ ์ „๋žต์„ ํฌํ•จ, ADME ์›์น™ ๋ฐ ์‹ ์•ฝ ๊ฐœ๋ฐœ ์›Œํฌํ”Œ๋กœ์šฐ์— ๋Œ€ํ•œ ์‹ฌ๋„ ์žˆ๋Š” ์ดํ•ด
  • PK ๋ฐ์ดํ„ฐ์˜ ๋น„๊ตฌํš ๋ถ„์„(NCA) ๊ฒฝํ—˜
  • GLP ๋ฐ GCP ๊ทœ์ •๊ณผ ์ด๋ฅผ ๋ฐ”์ด์˜ค ๋ถ„์„ ๋ฐ ์ž„์ƒ ์—ฐ๊ตฌ ํ™˜๊ฒฝ์— ์ ์šฉํ•˜๋Š” ๋ฐฉ๋ฒ•์— ๋Œ€ํ•œ ์‹ค๋ฌด ์ง€์‹ ๋ฐ ์ˆ™๋‹ฌ
  • ์‹ ์•ฝ๊ฐœ๋ฐœ ํ”„๋กœ์„ธ์Šค ๋ฐ ์•ฝ๋™ํ•™(PK)์— ๋Œ€ํ•œ ์ดํ•ด
  • CRO ๋˜๋Š” ์™ธ๋ถ€ ํŒŒํŠธ๋„ˆ์™€์˜ ํ˜‘์—… ๊ฒฝํ—˜
  • ๋ฐ์ดํ„ฐ ํ•ด์„ ๋ฐ ๋ฌธ์ œ ํ•ด๊ฒฐ ๋Šฅ๋ ฅ

์šฐ๋Œ€์‚ฌํ•ญ

  • ADC ๋˜๋Š” ๋ณต์žกํ•œ biologics ๋ถ„์„ ๊ฒฝํ—˜ ๋ณด์œ ์ž
  • Bioanalytical assay ๊ฐœ๋ฐœ ๋ฐ validation ๊ฒฝํ—˜
  • ADME ์—ฐ๊ตฌ ๊ฒฝํ—˜
  • IND/IB ๋“ฑ ๊ทœ์ œ ๋ฌธ์„œ ์ž‘์„ฑ ๊ฒฝํ—˜
  • PK/PD ๋ชจ๋ธ๋ง ๋ฐ ์‹œ๋ฎฌ๋ ˆ์ด์…˜, ์ง‘๋‹จ ์•ฝ๋™ํ•™(PopPK) ๋ถ„์„, ๋ฉ”ํƒ€ ๋ถ„์„ ์‹ค๋ฌด ๊ฒฝํ—˜
  • ๊ธ€๋กœ๋ฒŒ ํ™˜๊ฒฝ์—์„œ์˜ ํ˜‘์—… ๋ฐ ์ปค๋ฎค๋‹ˆ์ผ€์ด์…˜ ๊ฒฝํ—˜
  • ๋น ๋ฅด๊ฒŒ ๋ณ€ํ™”ํ•˜๋Š” ์กฐ์ง์—์„œ์˜ ์—…๋ฌด ์ˆ˜ํ–‰ ๊ฒฝํ—˜
  • ๋†’์€ ์ฑ…์ž„๊ฐ๊ณผ ์ฃผ๋„์„ฑ, ์‹คํ–‰๋ ฅ
  • ๋‹ค์ˆ˜์˜ ํ”„๋กœ์ ํŠธ๋ฅผ ํšจ๊ณผ์ ์œผ๋กœ ๊ด€๋ฆฌํ•  ์ˆ˜ ์žˆ๋Š” ์—ญ๋Ÿ‰


์ด๋ ฅ์„œ๋Š” ๋‹น์‚ฌ ๊ณต์‹ ์ฑ„์šฉ ํ™ˆํŽ˜์ด์ง€(Careers | Apply Now โ€” Orum Therapeutics)๋ฅผ ํ†ตํ•œ ์ง€์›์„ ์šฐ์„ ์‹œํ•ฉ๋‹ˆ๋‹ค.
์ง€์› ์‹œ *์˜๋ฌธ ์ด๋ ฅ์„œ(ํ•„์ˆ˜)์™€ ๊ตญ๋ฌธ ์ด๋ ฅ์„œ๋ฅผย ํ•˜๋‚˜์˜ PDF ํŒŒ์ผ๋กœ ์ €์žฅํ•˜์—ฌ ์—…๋กœ๋“œํ•ด์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.
โ€ป ํ•œ๊ธ€(HWP/Word) ํŒŒ์ผ์€ ์˜ค๋ฅ˜๊ฐ€ ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ์œผ๋ฏ€๋กœ ์ œ์ถœ์„ ์ง€์–‘ํ•ด์ฃผ์„ธ์š”.
์ด๋ ฅ์„œ ๋‚ด์—๋Š” ์—ฐ๋ด‰ ์ •๋ณด๋ฅผ ๊ธฐ์žฌํ•˜์ง€ ๋ง๊ณ , ์ง€์›์„œ ์ž…๋ ฅ๋ž€์—๋งŒ ์ž‘์„ฑํ•ด์ฃผ์„ธ์š”.ย 

โ€ป ์ž๊ฒฉ ์š”๊ฑด ๋ฐ ๊ฒฝ๋ ฅ์— ๋”ฐ๋ผ ์ง๊ธ‰๊ณผ ์ฒ˜์šฐ๋Š” ํ˜‘์˜ํ•˜์—ฌ ๋‚ด๋ถ€ ๊ทœ์ •์— ๋”ฐ๋ผ ์ตœ์ข… ๊ฒฐ์ •๋ฉ๋‹ˆ๋‹ค. ์ฑ„์šฉ ํ˜•ํƒœ ๋ฐ ์ˆ˜์Šต๊ธฐ๊ฐ„์€ ๊ด€๋ จ ๋ฒ•๋ น๊ณผ ํšŒ์‚ฌ ์ •์ฑ…์— ๋”ฐ๋ผ ์ ์šฉ๋˜๋ฉฐ, ์„ธ๋ถ€ ์‚ฌํ•ญ์€ ์ฑ„์šฉ ๊ณผ์ •์—์„œ ์•ˆ๋‚ด๋ฉ๋‹ˆ๋‹ค.



Orum Therapeutics is seeking a highly motivated and accomplished scientist to lead the Bioanalytical (BioA) and PK/PD function. This role is designed for a technical expert who thrives at the intersection of large and small molecule analysis, specifically focused on the complex characterization of Antibody-Drug Conjugates (ADCs). As a key scientific lead, you will orchestrate the bioanalytical lifecycle โ€” from internal method innovation to global CRO oversight โ€” ensuring high-quality data generation in a GLP/GCP environment. Beyond assay management, you will serve as a strategic partner in project teams, leveraging pharmacokinetic modeling to translate data into actionable insights that drive candidate selection and program progression.



Principal Duties and Responsibilities

  • Design and execute integrated Bioanalytical and PK/PD strategies for ADC programs, utilizing the three-analyte quantification approach (Total Ab, Conjugated, and Free Payload) from lead optimization to IND filing.
  • Oversee in vitro and in vivo ADME studies, including payload metabolism, drug-drug interactions (DDI), and transporter assays, to define the metabolic fate of the ADC and the released payload.
  • Provide high-level technical oversight for hybrid bioanalytical workflows, specifically bridging LBA and LC-MS/MS platforms to ensure robust quantification of complex modalities.
  • Lead CRO selection and management, serving as the primary point of contact for method transfer, development, validation, and troubleshooting of proprietary assays under aggressive timelines.
  • Review and approve SOPs, validation reports, and bioanalytical study plans in alignment with GLP/GCP standards and current FDA guidance.
  • Act as the BioA/PK subject matter expert (SME) within multidisciplinary project teams, collaborating with Research & Development and Clinical teams to drive program milestones.
  • Drive continuous improvement by evaluating emerging technologies to enhance the throughput and quality of ADC characterization.
  • Execute an integrated role that bridges high-level scientific leadership and direct lab-based contributions, ensuring seamless translation from internal innovation to external CRO execution.
  • Serve as the lead author for BioA and PK sections of regulatory submissions (IND/IB), ensuring full compliance with GLP/GCP and current FDA/EMA bioanalytical guidance.


Skills, Abilities & Competencies

  • Extensive experience in pharmacokinetic (PK) and biodistribution studies of Antibody-Drug Conjugates (ADCs), including application of advanced bioanalytical methods such as LC-MS/MS for small-molecule quantitation and MSD-based ligand-binding assays (LBAs).
  • Proven track record in developing, validating, and implementing bioanalytical assays for ADC modalities, including total antibody, free and conjugated payload, and anti-drug antibodies (ADA) assays, in support of preclinical and clinical PK studies.
  • In-depth understanding of ADME principles and drug discovery/development workflows, including screening strategies from early feasibility through candidate nomination.
  • Experience in non-compartmental analysis of PK data, with hands-on experience in PK/PD modeling and simulation, population PK analysis, and meta-analysis is a plus.
  • Working knowledge of GLP and GCP regulations and their application within bioanalytical and clinical study environments.
  • Demonstrated ability to operate independently in fast-paced biotech settings while effectively collaborating within cross-functional, global teams.
  • Excellent communication, organizational, and time-management skills, with the ability to manage multiple priorities and deliver high-quality results.
  • Strong work ethic with a high degree of accountability, initiative, and ability to work with minimal supervision.


Education

Ph.D. or equivalent degree in Analytical Chemistry or a related field with a minimum of 5 years' experience. Level will be commensurate with experience and accomplishments.


Applications areย prioritizedย through our official careers website(Careers | Apply Now โ€” Orum Therapeutics).
Please combine your English (required) and Korean CVย  into a single PDF file before uploading.
โ€ป Submissions in HWP/Word format may cause file errors and are not recommended.
Please remove any salary information from your CV; such details should be entered only in the application form.

โ€ป Career level, Employment type and any probationary period will be applied in accordance with applicable laws and company policy, with further details provided during the hiring process.